Please ensure Javascript is enabled for purposes of website accessibility

News

Sep 30, 2019

Balance of power

Control of the General Assembly is at stake in pivotal fall election

Sep 30, 2019

House of Delegates races to watch

House of Delegates races to watch

Sep 30, 2019

Virginia Senate races to watch

Virginia Senate races to watch

Sep 30, 2019

Building on success

OCTOBER INTERVIEW with Lara Fritts, president and CEO, Greater Richmond Partnership

Sep 30, 2019

Cities from scratch

Major developments are transforming Northern Virginia’s landscape

Sep 30, 2019

Game changer

Companies use competition to make employee wellness fun

Sep 30, 2019

Off the beaten path

Companies eschew traditional team-building for oddball excursions

Sep 30, 2019

Bringing in the big bucks

Virginia’s CEOs received an average pay increase of 12.5% last year, with the top earner reaping $39 million

Sep 30, 2019

Innovative thinking

College Profile of William & Mary

Sep 30, 2019

The art of growth

Suffolk sees surge from downtown renewal, mixed-use projects

Sep 30, 2019

VCU holding 29th Real Estate Trends Conference

Speakers will address economic trends and cities as a service.

Sep 30, 2019

Landos Biopharma’s promising anti-inflammation drug moves into Phase II trials

Landos Biopharma’s anti-inflammation drug, BT-11, moves into Phase II trials.

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.